Patrick Y. Jay

2.7k total citations
69 papers, 1.8k citations indexed

About

Patrick Y. Jay is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Patrick Y. Jay has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 29 papers in Cardiology and Cardiovascular Medicine and 18 papers in Epidemiology. Recurrent topics in Patrick Y. Jay's work include Congenital heart defects research (28 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Cardiomyopathy and Myosin Studies (11 papers). Patrick Y. Jay is often cited by papers focused on Congenital heart defects research (28 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Cardiomyopathy and Myosin Studies (11 papers). Patrick Y. Jay collaborates with scholars based in United States, United Kingdom and France. Patrick Y. Jay's co-authors include Seigo Izumo, Julie R. McMullen, William T. Pu, David B. Wilson, Jonathan M. Erlich, Małgorzata Bielińska, Markku Heikinheimo, Charles I. Berul, Kai‐Chien Yang and Makoto Tanaka and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Patrick Y. Jay

63 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Y. Jay United States	22	1.1k	627	276	266	210	69	1.8k
Christian Kühn Germany	22	847 0.8×	703 1.1×	170 0.6×	202 0.8×	121 0.6×	65	1.9k
Faqian Li United States	30	1.5k 1.3×	564 0.9×	342 1.2×	373 1.4×	111 0.5×	88	2.3k
Josef G. Heuer United States	20	818 0.7×	357 0.6×	186 0.7×	121 0.5×	137 0.7×	34	1.7k
Andreas Perrot Germany	35	1.8k 1.6×	2.1k 3.4×	444 1.6×	162 0.6×	197 0.9×	71	3.1k
Joachim P. Schmitt Germany	21	2.3k 2.0×	2.1k 3.3×	417 1.5×	334 1.3×	268 1.3×	52	3.5k
Takayoshi Matsumura Japan	22	830 0.7×	299 0.5×	178 0.6×	225 0.8×	114 0.5×	58	1.5k
A. F. M. Moorman Netherlands	18	1.2k 1.0×	473 0.8×	253 0.9×	292 1.1×	165 0.8×	36	1.5k
Roy A. Lynch United States	12	1.1k 0.9×	718 1.1×	193 0.7×	164 0.6×	195 0.9×	16	1.9k
Linda L. Bachinski United States	30	2.0k 1.8×	2.1k 3.4×	200 0.7×	279 1.0×	194 0.9×	51	3.7k
Jeanne James United States	26	1.0k 0.9×	949 1.5×	180 0.7×	96 0.4×	152 0.7×	40	1.8k

Countries citing papers authored by Patrick Y. Jay

Since Specialization

Citations

This map shows the geographic impact of Patrick Y. Jay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Y. Jay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Y. Jay more than expected).

Fields of papers citing papers by Patrick Y. Jay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Y. Jay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Y. Jay. The network helps show where Patrick Y. Jay may publish in the future.

Co-authorship network of co-authors of Patrick Y. Jay

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Y. Jay. A scholar is included among the top collaborators of Patrick Y. Jay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Y. Jay. Patrick Y. Jay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mesquita, Cláudio Tinoco, Pedro Vellosa Schwartzmann, Marcus Vinícius Simões, et al.. (2025). Patisiran Treatment in the Brazilian Subpopulation of the Phase 3 APOLLO-B Study in Transthyretin Amyloidosis with Cardiomyopathy: Post Hoc Analysis. Arquivos Brasileiros de Cardiologia. 122(4).

Mesquita, Cláudio Tinoco, Pedro Vellosa Schwartzmann, Marcus Vinı́cius Simões, et al.. (2025). Tratamento com Patisirana na Subpopulação Brasileira do Estudo de Fase 3 APOLLO-B em Amiloidose por Transtirretina com Cardiomiopatia: Análise Post Hoc. Arquivos Brasileiros de Cardiologia. 122(4). e20240568–e20240568.

Maurer, Matthew J., et al.. (2025). Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and Cardiomyopathy in the APOLLO-B Trial. Journal of the American College of Cardiology. 85(7). 744–752. 1 indexed citations

Jering, Karola, Marianna Fontana, Olivier Lairez, et al.. (2025). Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial. Nature Medicine. 31(10). 3560–3568. 2 indexed citations

Lairez, Olivier, et al.. (2024). Long-term effects of patisiran on survival and cardiac parameters in patients with transthyretin-mediated cardiac amyloidosis: post hoc analysis of APOLLO-B and cardiac subpopulation of APOLLO OLE. European Heart Journal. 45(Supplement_1). 1 indexed citations

Fontana, Marianna, John L. Berk, Mazen Hanna, et al.. (2023). Patisiran treatment for ATTR cardiac amyloidosis: 18-month results of the phase 3 APOLLO-B study. Archives of cardiovascular diseases. 117(1). S34–S35. 1 indexed citations

Badri, Prajakta, Bahru Habtemariam, Valerie A. Clausen, et al.. (2023). Pharmacokinetics and Pharmacodynamics of Patisiran in Patients with hATTR Amyloidosis and with Polyneuropathy After Liver Transplantation. Clinical Pharmacokinetics. 62(10). 1509–1522. 4 indexed citations

Hung, Rebecca R., Edileide de Barros Correia, John L. Berk, et al.. (2023). Abstract 13273: APOLLO-B, a Study of Patisiran in Patients With Transthyretin Cardiac Amyloidosis: Primary Long-Term Results From the Open-Label Extension Period. Circulation. 148(Suppl_1). 5 indexed citations

Walton, Nephi, et al.. (2023). Repurposing Normal Chromosomal Microarray Data to Harbor Genetic Insights into Congenital Heart Disease. Biology. 12(10). 1290–1290. 3 indexed citations

10.

Heitmeier, Monique R., Maria Payne, Carla J. Weinheimer, et al.. (2018). Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia. Scientific Reports. 8(1). 6475–6475. 10 indexed citations

11.

Udager, Aaron M., Ajay Prakash, Martina Schinke, et al.. (2013). Proper Development of the Outer Longitudinal Smooth Muscle of the Mouse Pylorus Requires Nkx2-5 and Gata3. Gastroenterology. 146(1). 157–165.e10. 13 indexed citations

12.

Kyrönlahti, Antti, Melanie Vetter, Małgorzata Bielińska, et al.. (2011). GATA4 Deficiency Impairs Ovarian Function in Adult Mice1. Biology of Reproduction. 84(5). 1033–1044. 46 indexed citations

13.

Mitra, Mayurranjan S., Joel D. Schilling, Xiaowei Wang, et al.. (2011). Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axis. Journal of Molecular and Cellular Cardiology. 51(1). 120–128. 39 indexed citations

14.

Erlich, Jonathan M., Courtney Green, Robert Barlow, et al.. (2010). Heterogeneity of Genetic Modifiers Ensures Normal Cardiac Development. Circulation. 121(11). 1313–1321. 52 indexed citations

15.

Sabirzhanov, Boris, et al.. (2009). Activation of Tolloid‐like 1 gene expression by the cardiac specific homeobox gene Nkx2–5. Development Growth & Differentiation. 51(4). 403–410. 7 indexed citations

16.

Wong, Michelle, Beth L. Viviano, Jonathan M. Erlich, et al.. (2009). Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development. Developmental Biology. 335(1). 208–215. 49 indexed citations

17.

Jay, Patrick Y., Małgorzata Bielińska, Jonathan M. Erlich, et al.. (2006). Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects. Developmental Biology. 301(2). 602–614. 131 indexed citations

18.

Jay, Patrick Y., Colin T. Maguire, Hiroko Wakimoto, Seigo Izumo, & Charles I. Berul. (2005). Absence of Msx2 Does Not Affect Cardiac Conduction or Rescue Conduction Defects Associated with Nkx2‐5 Mutation. Journal of Cardiovascular Electrophysiology. 16(1). 81–85. 7 indexed citations

19.

Jay, Patrick Y., Charles I. Berul, Makoto Tanaka, et al.. (2003). Cardiac Conduction and Arrhythmia: Insights from Nkx2.5 Mutations in Mouse and Humans. Novartis Foundation symposium. 250. 227–241. 22 indexed citations

20.

Tanaka, Makoto, Charles I. Berul, Masao Ishii, et al.. (2002). A Mouse Model of Congenital Heart Disease: Cardiac Arrhythmias and Atrial Septal Defect Caused by Haploinsufficiency of the Cardiac Transcription Factor Csx/Nkx2.5. Cold Spring Harbor Symposia on Quantitative Biology. 67(0). 317–326. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact